Skip to main
  1. Stocks
  2. NRC Health
  3. Forecast
NRC

NRC Health (NRC) Stock Forecast & Price Target

NRC Health (NRC) Analyst Ratings

Based on 1 analyst ratings
Buy
Strong Buy 0%
Buy 100%
Hold 0%
Sell 0%
Strong Sell 0%

Bulls say

NRC Health is attractive because its 3Q26 results showed both revenue and profitability ahead of expectations, with $38.4M of revenue and $10.9M of EBITDA supported by recurring subscription demand and a successful large customer go-live. The company’s visibility is reinforced by a $154M TRCV base, multi-year renewals, and a second phase of the large customer’s rollout scheduled for 3Q27, while management expects sequential margin improvement in 4Q and analysts see revenue growth resuming in 2026 and strengthening in 2027. Its differentiated healthcare-specific platform, Best in KLAS recognition, expanding cross-sell opportunity, and improving execution under new leadership support the view that NRC can rebuild top-line growth and move back toward higher historical profitability.

Bears say

NRC Health is facing a weak fundamental setup because industry consolidation may lengthen sales cycles, while attempts to reaccelerate Insights and TGI growth may fall short and leave expense assumptions too optimistic. Profitability is also pressured by elevated investment in product and personnel, with SG&A approximating 40% of revenue in 2025, or 31% excluding one-time and non-cash items, up from 30% in 2024, suggesting limited near-term margin expansion. The company’s dependence on a concentrated customer base, potential leverage increases from dividends and buybacks, and thin liquidity with a 12M-share float and under 125K average daily volume further weaken the risk-reward profile.

NRC Health (NRC) has been analyzed by 1 analysts, with a consensus rating of Buy. 0% of analysts recommend a Strong Buy, 100% recommend Buy, 0% suggest Holding, 0% advise Selling, and 0% predict a Strong Sell.

This aggregate rating is based on analysts' research of NRC Health and is not a guaranteed prediction by Public.com or investment advice.

NRC Health (NRC) Analyst Forecast & Price Prediction

Get the latest NRC Health (NRC) stock forecast, including analyst ratings and price predictions, with real-time AI-powered fundamental data and custom analysis

Start investing in NRC Health (NRC)

Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy

FAQs About NRC Health (NRC) Forecast

Analysts have given NRC Health (NRC) a Buy based on their latest research and market trends.

According to 1 analysts, NRC Health (NRC) has a Buy consensus rating as of Nov 13, 2026. This rating is provided by third-party analysts and is not investment advice from Public.com.

Wall Street analysts have set a price target of $27, reflecting a 0.00% increase from the current stock price.

Financial analysts have set a price target of $27, indicating a 0.00% increase from the current stock price, but ratings and forecasts are frequently updated based on market conditions, earnings reports, and industry trends. This prediction is provided by third-party analysts and is not investment advice from Public.com.

NRC Health (NRC)


NRC Health (NRC) Analyst Forecast & Price Prediction

Get the latest NRC Health (NRC) stock forecast, including analyst ratings and price predictions, with real-time AI-powered fundamental data and custom analysis

Start investing in NRC Health (NRC)

Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy
Disclaimer: Any investment listed here, which may be available on the Public platform, is intended to be used for informational purposes only, should not be the sole basis for making an investment decision, and is not a recommendation or advice.
Uncover NRC stock data and trends